Overview of the Class Action

The Rosen Law Firm, an internationally recognized leader in investor rights, has issued a reminder to individuals who purchased common stock in Integral Ad Science Holding Corp. (NASDAQ: IAS) between March 2, 2023, and February 27, 2024. Investors are urged to be aware of the critical deadline of March 31, 2025, for submitting lead plaintiff motions in the ongoing class action lawsuit.

Your Rights and Potential Compensation

If you acquired shares of IAS during the designated class period, you may be entitled to financial compensation. Importantly, this can be achieved without any out-of-pocket expenses thanks to a contingency fee arrangement with the firm.

Next Steps for Interested Investors

If you wish to participate in the class action or serve as a lead plaintiff, you can learn more and submit your information by visiting Rosen Legal’s submission form. Additionally, you’re welcome to contact Phillip Kim, Esq. toll-free at 866-767-3653 or reach out via email at ca**@ro********.com for further assistance.

Be mindful that while the lawsuit is ongoing, a class has yet to be certified. Until then, you are not represented by counsel unless you select one personally.

Why Choose Rosen Law Firm?

When selecting counsel for your case, the Rosen Law Firm emphasizes the importance of choosing qualified attorneys with a proven history of success. The firm has garnered recognition as a top performer in securities class actions, including achieving a record settlement against a Chinese company and securing over $438 million for investors in 2019 alone. Founding partner Laurence Rosen was named a “Titan of Plaintiffs’ Bar” by Law360 in 2020, showcasing the firm’s exemplary accolades and extensive experience in handling securities litigation.

Details of the Case

The lawsuit against Integral Ad Science claims that the company did not adequately inform investors about several critical factors during the class period. Allegations include:

• Significant competitive pricing pressures forcing IAS to reduce prices amid declining demand.
• The unfeasibility of maintaining favorable pricing, impacting the company’s competitive edge.
• Risks related to increased pricing pressures that materialized impacting the companies’ public communication.

As these details became public, it is claimed that investors suffered considerable damages.